Emvistegrast
Emvistegrast is a quinolone derivative. Emvistegrast is an antagonist of α4β7 integrin. Emvistegrast can be studied in research for diseases that are mediated by α4β7 integrin, such as infkammatory bowel disease[1].
Product Specifications
CAS Number
[2417352-91-9]
Product Name Alternative
GS-1427
UNSPSC
12352005
Target
Integrin
Related Pathways
Cytoskeleton
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
CCOC([C@H](CC1=CC=C(N2C(N(C3=C(C2=O)C=CN=C3)C)=O)C4=C1C=CC=N4)NC(C5=C(C=C(C=C5F)N6[C@H](COCC6)C(F)(F)F)C)=O)=O
Molecular Formula
C35H32F4N6O6
Molecular Weight
708.66
References & Citations
[1]Peter A. Blomgren, et al., Quinoline derivatives as alpha4beta7 integrin inhibitors. WO2020092375A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
V2095-03A-ML650 100 µL
VAP1, ID (Membrane Primary Amine Oxidase, Copper Amine Oxidase, Semicarbazide-sensitive Amine Oxidase, SSAO, Vascular Adhesion Protein 1, VAP-1, HPAO, AOC3) (MaxLight 650) discontinued
Ask
View Details